2021

1. Cost-effectiveness analysis of defibrotide in the treatment of patients with severe veno-occlusive disease/sinusoidal obstructive syndrome with multiorgan dysfunction following hematopoietic cell transplantation in Spain

   Journal of Medical Economics, Vol. 24, Núm. 1, pp. 628-636